Literature DB >> 21946380

Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients.

J-C Ianotto, A Tempescul, X Yan, P Delepine, R Le Calloch, E Hardy, J-R Eveillard, N Mugnier, C Berthou, G Guillerm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21946380     DOI： 10.1038/bmt.2011.189

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimens.

Authors:  Simona Bassi; Elisa M Stroppa; Carlo F Moroni; Maria C Arbasi; Elena Trabacchi; Anna Di Franco; Antonio Lazzaro; Patrizia Bernuzzi; Mauro Moretto; Annalisa Arcari; Costanza Bosi; Alessandra Riva; Luigi Cavanna; Daniele Vallisa
Journal:  Blood Transfus       Date:  2015-02-02       Impact factor: 3.443

2.  Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR).

Authors:  Alberto Bongiovanni; Manuela Monti; Flavia Foca; Federica Recine; Nada Riva; Valentina Di Iorio; Chiara Liverani; Alessandro De Vita; Giacomo Miserocchi; Laura Mercatali; Dino Amadori; Toni Ibrahim
Journal:  Support Care Cancer       Date:  2016-08-27       Impact factor: 3.603

Review 3.  Clinical experience with Zarzio® in Europe: what have we learned?

Authors:  Pere Gascón; Hans Tesch; Karl Verpoort; Maria Sofia Rosati; Nello Salesi; Samir Agrawal; Nils Wilking; Helen Barker; Michael Muenzberg; Matthew Turner
Journal:  Support Care Cancer       Date:  2013-08-01       Impact factor: 3.603

Review 4.  Biosimilar granulocyte-colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?

Authors:  Halvard Bonig; Petra S Becker; Arnd Schwebig; Matthew Turner
Journal:  Transfusion       Date:  2014-06-26       Impact factor: 3.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.